Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Sims

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infectionJessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
Journal of Clinical Microbiology|July 10, 2020
Performance of PCR/Electrospray Ionization-Mass Spectrometry on Whole Blood for Detection of Bloodstream Microorganisms in Patients with Suspected SepsisKristoffer Strålin, Richard E Rothman, Volkan Özenci, et al.
Chest|July 3, 2020
PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the ICUStephen P Bergin, Adrian Coles, Sara B Calvert, et al.
Open Forum Infectious Diseases|July 15, 2022
PROPHETIC EU: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit in European and United States CohortsStephen P Bergin, Sara B Calvert, John Farley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2023
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based TherapeuticCharles S Berenson, Bret Lashner, Louis Y Korman, et al.
Cell Metabolism|February 7, 2006
A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balanceYung Seng Lee, Ben G Challis, Darren A Thompson, et al.
Intensive Care Medicine|October 9, 2024
Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectoriesSivasubramanium V Bhavani, Alexandra Spicer, Pratik Sinha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2019
The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)Thomas P Lodise, Susan L Rosenkranz, Matthew Finnemeyer, et al.
The New England Journal of Medicine|January 19, 2022
SER-109, an Oral Microbiome Therapy for Recurrent <i>Clostridioides difficile</i> InfectionPaul Feuerstadt, Thomas J Louie, Bret Lashner, et al.
Infectious Diseases and Therapy|June 28, 2024
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDIColleen S Kraft, Matthew Sims, Michael Silverman, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infectionJessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
Journal of Clinical Microbiology|July 10, 2020
Performance of PCR/Electrospray Ionization-Mass Spectrometry on Whole Blood for Detection of Bloodstream Microorganisms in Patients with Suspected SepsisKristoffer Strålin, Richard E Rothman, Volkan Özenci, et al.
Chest|July 3, 2020
PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the ICUStephen P Bergin, Adrian Coles, Sara B Calvert, et al.
Open Forum Infectious Diseases|July 15, 2022
PROPHETIC EU: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit in European and United States CohortsStephen P Bergin, Sara B Calvert, John Farley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2023
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based TherapeuticCharles S Berenson, Bret Lashner, Louis Y Korman, et al.
Cell Metabolism|February 7, 2006
A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balanceYung Seng Lee, Ben G Challis, Darren A Thompson, et al.
Intensive Care Medicine|October 9, 2024
Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectoriesSivasubramanium V Bhavani, Alexandra Spicer, Pratik Sinha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2019
The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)Thomas P Lodise, Susan L Rosenkranz, Matthew Finnemeyer, et al.
The New England Journal of Medicine|January 19, 2022
SER-109, an Oral Microbiome Therapy for Recurrent <i>Clostridioides difficile</i> InfectionPaul Feuerstadt, Thomas J Louie, Bret Lashner, et al.
Infectious Diseases and Therapy|June 28, 2024
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDIColleen S Kraft, Matthew Sims, Michael Silverman, et al.
Pageof 4